drugset / Trial / NCT00447928

Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow

NCT00447928

Phase 2 Unknown 164 enrolled Cure Therapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the effectiveness and safety of the use of low-dose nitroglycerin transdermal patches to treat pain and function in chronic tennis elbow.

Timeline

Start
2007-04
Primary completion
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown 0.72 mg Other
Subject Nitroglycerin Unknown 1.44 mg Other
Subject Nitroglycerin Unknown 3.6 mg Other

Indications